Thermo Fisher Scientific (TMO) Consolidated Net Income (2009 - 2026)

Thermo Fisher Scientific has reported Consolidated Net Income for 18 years, with the latest figure at $1.8 billion in Q2 2026.

• Consolidated Net Income for Q2 2026 came in at $1.8 billion, up 8.66% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.0 billion (up 7.06% YoY), and the FY2025 annual result was $6.8 billion, up 5.97% from the prior year.
• Consolidated Net Income climbed to $1.8 billion in Q2 2026, from $1.7 billion in the prior quarter.
• Over five years, Consolidated Net Income peaked at $2.2 billion in Q2 2022 and troughed at $1.3 billion in Q1 2024.
• A 5-year average of $1.7 billion and a median of $1.6 billion in 2024 frame the typical range for Consolidated Net Income.
• The widest annual swing landed in 2023, when Consolidated Net Income plunged 41.18%; it then gained 18.8% in 2024.
• A 5-year view of Consolidated Net Income shows it stood at $1.6 billion in 2022, then gained by 0.19% to $1.6 billion in 2023, then gained by 11.45% to $1.8 billion in 2024, then climbed by 11.67% to $2.0 billion in 2025, then declined by 12.15% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were $1.8 billion in Q2 2026, $1.7 billion in Q1 2026, and $2.0 billion in Q4 2025.